Hypera Sa Stock Performance
| HYPMY Stock | USD 4.94 0.24 5.11% |
On a scale of 0 to 100, Hypera SA holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of 1.82, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Hypera SA will likely underperform. Please check Hypera SA's value at risk, as well as the relationship between the kurtosis and period momentum indicator , to make a quick decision on whether Hypera SA's current trending patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Hypera SA are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Hypera SA showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 4.7 B | |
| Total Cashflows From Investing Activities | -4.4 B |
Hypera |
Hypera SA Relative Risk vs. Return Landscape
If you would invest 436.00 in Hypera SA on October 29, 2025 and sell it today you would earn a total of 58.00 from holding Hypera SA or generate 13.3% return on investment over 90 days. Hypera SA is currently producing 0.3174% returns and takes up 4.746% volatility of returns over 90 trading days. Put another way, 42% of traded pink sheets are less volatile than Hypera, and 94% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Hypera SA Target Price Odds to finish over Current Price
The tendency of Hypera Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.94 | 90 days | 4.94 | about 6.68 |
Based on a normal probability distribution, the odds of Hypera SA to move above the current price in 90 days from now is about 6.68 (This Hypera SA probability density function shows the probability of Hypera Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 1.82 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Hypera SA will likely underperform. Additionally Hypera SA has an alpha of 0.234, implying that it can generate a 0.23 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Hypera SA Price Density |
| Price |
Predictive Modules for Hypera SA
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hypera SA. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Hypera SA Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Hypera SA is not an exception. The market had few large corrections towards the Hypera SA's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hypera SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hypera SA within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.23 | |
β | Beta against Dow Jones | 1.82 | |
σ | Overall volatility | 0.30 | |
Ir | Information ratio | 0.06 |
Hypera SA Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hypera SA for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hypera SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hypera SA had very high historical volatility over the last 90 days |
Hypera SA Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hypera Pink Sheet often depends not only on the future outlook of the current and potential Hypera SA's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hypera SA's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 639.5 M | |
| Cash And Short Term Investments | 2.3 B |
Hypera SA Fundamentals Growth
Hypera Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Hypera SA, and Hypera SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hypera Pink Sheet performance.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0686 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.33 % | |||
| Current Valuation | 6.39 B | |||
| Shares Outstanding | 631.94 M | |||
| Price To Earning | 19.85 X | |||
| Price To Book | 2.52 X | |||
| Price To Sales | 0.72 X | |||
| Revenue | 5.94 B | |||
| EBITDA | 1.87 B | |||
| Cash And Equivalents | 1.5 B | |||
| Cash Per Share | 2.37 X | |||
| Total Debt | 6.8 B | |||
| Debt To Equity | 0.80 % | |||
| Book Value Per Share | 16.57 X | |||
| Cash Flow From Operations | 1.4 B | |||
| Earnings Per Share | 0.49 X | |||
| Total Asset | 19.82 B | |||
| Retained Earnings | 2.62 B | |||
| Current Asset | 6.68 B | |||
| Current Liabilities | 1.63 B | |||
About Hypera SA Performance
Evaluating Hypera SA's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Hypera SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hypera SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypermarcas ADR operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9000 people.Things to note about Hypera SA performance evaluation
Checking the ongoing alerts about Hypera SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Hypera SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hypera SA had very high historical volatility over the last 90 days |
- Analyzing Hypera SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hypera SA's stock is overvalued or undervalued compared to its peers.
- Examining Hypera SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hypera SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hypera SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hypera SA's pink sheet. These opinions can provide insight into Hypera SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Hypera Pink Sheet Analysis
When running Hypera SA's price analysis, check to measure Hypera SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypera SA is operating at the current time. Most of Hypera SA's value examination focuses on studying past and present price action to predict the probability of Hypera SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypera SA's price. Additionally, you may evaluate how the addition of Hypera SA to your portfolios can decrease your overall portfolio volatility.